Luxara Labs · Testing & Transparency
Canada’s most extensively tested peptide supplier.
Extensive third-party testing. Public Certificates of Analysis. Clear lot references. Luxara Labs gives Canadian researchers access to the documentation behind their next research order.
Trust built on accessible evidence
Looking for a trustworthy peptide company in Canada?
Your research supplier should make it straightforward to inspect its documentation, identify the relevant lot, and reach a real company with questions. At Luxara Labs, these are practical parts of the buying experience.
Review the evidence first
Our public COA directory gives you access to laboratory findings before you order. Examine the original report alongside the result summary.
Know what the result describes
Published entries identify the compound, lot, testing date, reported purity, and measured content where available. These details help you connect a product to the corresponding tested sample.
Reach us directly
Call 289-588-7939 or email info@luxaralabs.com for documentation and order questions. Ask about the available lot before purchasing.
Choose with useful context
Our guides explain how to read a COA and interpret purity , helping you evaluate the findings and their relevance to your research.
The evidence behind the milestone
Recent laboratory results, open for review.
Our latest published examples are dated October 17, 2026. Open each full COA to examine its sample identification, analytical methods, and reported findings.
LOT B11955 · OCTOBER 17, 2026
BPC-157
- Reported purity
- 99.6%
- Measured content
- 10.17 mg
LOT BT2095 · OCTOBER 17, 2026
BPC-157 / TB-500 Blend
- Component purities
- 99.79% / 99.81%
- Total content reported
- 23.75 mg
COA component order: Thymosin β4, then BPC-157. Review the full report for component amounts.
LOT M49565 · OCTOBER 17, 2026
MOTS-C
- Reported purity
- 99.8%
- Measured content
- 50.35 mg
LOT S51224 · OCTOBER 17, 2026
SS-31
- Reported purity
- 99.8%
- Measured content
- 66.06 mg
Source: the linked laboratory reports and Luxara Labs’ results directory . Reports describe the samples tested, not measurements of every vial or certification of an entire batch. The 37-result count refers to published lot-associated result entries, not individual analytical procedures. Product availability and supplied lots may change.
Ready to explore the research catalog? Compare available compounds and strengths, with the documentation close at hand.
Browse the Full Shop →A clear path to verification
Match the material. Read the report.
Documentation is useful when you can connect it to the product you are evaluating.
Read our complete COA guide →- Identify the compound and labeled strength. For blends, check the constituents as well as the total quantity.
- Locate the lot reference. Search the results directory by product or lot. Contact us if you need to confirm the available lot before ordering.
- Inspect the full COA. Read the sample details, dates, methods, and results. Distinguish declared strength from measured content.
- Compare the received vial with the documentation. Check its product label and lot number. Send us any missing-report or lot-matching question for review.
Understand what the evidence establishes
Different measurements. Different questions.
Third-party testing is meaningful when its scope is clear. The methods and conclusions on the individual report determine what a result supports.
Purity
Purity describes the tested sample according to the method used. Chromatographic area percentages are not automatically percentages by weight. Read the laboratory’s explanation of how the reported value was determined.
Measured content
Content analysis reports the measured quantity of the target compound or compounds. A purity percentage alone does not establish milligram content. Compare the declared amount and measured result as separate fields.
Identity-related analysis
Mass spectrometry can provide evidence supporting compound identification. Check whether it is documented on the specific report and how the laboratory states its conclusion.
Additional testing scope
Purity, content, and identity findings do not automatically establish sterility, endotoxin levels, heavy metals, residual solvents, or stability. Look for the relevant analysis for each requirement of your research.
An informed sourcing decision
What makes a peptide supplier reliable?
Reliability includes clear product information, documentation you can inspect, and a responsive point of contact. If you are searching for the best peptide company for your research requirements, use those practical checks to guide your decision.
At Luxara Labs, you can move directly from our published results to the relevant product page, compare available strengths, and contact us with lot or order questions before purchasing.
Read our Canadian peptide sourcing guide →Explore the supporting evidence
A connected research library.
Clear answers
Testing & transparency FAQs.
Why does Luxara Labs describe itself as Canada’s most extensively tested peptide supplier?
This positioning is based on Luxara Labs’ research into Canadian peptide suppliers. Our public testing record includes 37 lot-associated result entries dated August 14–October 17, 2026, alongside earlier reports in the COA directory. You can examine the available source reports and their analytical scope directly.
Where can I find Luxara Labs’ peptide COAs?
Visit the lab-results directory, search for the product or lot number, and open the corresponding COA PDF. Match the product, labeled strength, and lot to the material you are evaluating.
What does the 37-result milestone count?
It counts 37 lot-associated result entries dated August 14 through October 17, 2026, inclusive. It does not count individual analytical procedures or mean every vial in a lot was tested.
Does a high purity percentage establish milligram content?
No. Purity and measured content answer different questions. A purity percentage alone does not establish the milligrams present. Review both findings and the relevant methods where reported.
How can I confirm the available lot before ordering?
Contact Luxara Labs with the compound and strength you are considering. Request confirmation of the available lot and its corresponding documentation.
Does a COA certify every vial in a batch?
No. The report describes the submitted sample and the analyses performed. Its findings should not be extended to every vial or treated as certification of safety, efficacy, or regulatory approval.
Luxara Labs / Luxara Research Company
Published by Luxara Labs, operated by Luxara Research Inc. For documentation, lot matching, or order questions, email info@luxaralabs.com , call 289-588-7939, or contact our team . Include the product and lot reference where applicable.
Comparative positioning is based on Luxara Labs’ supplier research. Testing figures are drawn from the linked reports and public result entries. Last content update: October 17, 2026.
Source your next research order
Extensive testing. Transparent results. Luxara Labs.
Explore our research peptide catalog, compare available strengths, and review the supporting documentation before placing your order.